| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.22 | 6e-10 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.27 | 3e-08 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |